Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Doxazosin may cause breast enlargement and pain in men.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

These medications for BPH have known risks and may have new side effects.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

GI197111X is best dissolved in Capmul MCM for trials.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.